Attached files
| file | filename |
|---|---|
| EX-32.2 - CERTIFICATION OF OFFICER - CNS Pharmaceuticals, Inc. | cns_ex3202.htm |
| 10-K/A - AMENDMENT #2 TO THE ANNUAL REPORT - CNS Pharmaceuticals, Inc. | cns_10ka2-123120.htm |
| EX-32.1 - CERTIFICATION OF OFFICER - CNS Pharmaceuticals, Inc. | cns_ex3201.htm |
| EX-31.2 - CERTIFICATION BY OFFICER - CNS Pharmaceuticals, Inc. | cns_ex3102.htm |
| EX-4.3 - DESCRIPTION OF THE COMPANY'S SECURITIES - CNS Pharmaceuticals, Inc. | cns_ex0403.htm |
EXHIBIT 31.1
CERTIFICATION BY OFFICER
I, John Climaco, certify that:
| 1. | I have reviewed this Form 10-K/A for the year ended December 31, 2020 of CNS Pharmaceuticals, Inc.; |
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
| Date: April 30, 2021 | By: | /s/ John Climaco |
| John Climaco | ||
| Chief Executive Officer and President |